Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Cipla has reported consolidated financial results for the period ended September 30, 2021
FDA approval of the first interchangeable biosimilar insulin will drive the US Insulin biosimilar market, says Kuick Research.
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)